Authors: Carmon, L Tzehoval, E Tirosh, B el-Shami, KM Bar-Haim, E Vadai, E Feldman, M Eisenbach, L

Citation: L. Carmon et al., Anti-tumor vaccination in heterozygous congenic F1 mice: Presentation of tumor-associated antigen by the two parental class I alleles, J IMMUNOTH, 23(3), 2000, pp. 344-352

Authors: Eisenbach, L Bar-Haim, E El-Shami, K

Citation: L. Eisenbach et al., Antitumor vaccination using peptide based vaccines, IMMUNOL LET, 74(1), 2000, pp. 27-34

Authors: Tirosh, B el-Shami, K Vaisman, N Carmon, L Bar-Haim, E Vadai, E Feldman, M Fridkin, M Eisenbach, L

Citation: B. Tirosh et al., Immunogenicity of H-2K(b)-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination, IMMUNOL LET, 70(1), 1999, pp. 21-28

Authors: el-Shamil, K Tirosh, B Bar-Haim, E Carmon, L Vadai, E Fridkin, M Feldman, M Eisenbach, L

Citation: K. El-shamil et al., MHC class I-restricted epitope spreading in the context of tumor rejectionfollowing vaccination with a single immunodominant CTL epitope, EUR J IMMUN, 29(10), 1999, pp. 3295-3301